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Effects of Megestrol Acetate, 
A Progestin, on Female Rats 
LENORE SOUTHAM 
Abstract. Silastic (c:limethylpolysiloxane) capsules containing mege-
strol acetate ( 6- methyl-17 ex: -acetoxypregna-4, 6- diene-3, 20-dione) 
were implanted subcutaneously in mature female rats. The effects of 
megestrol on the ovary, on fertility, on body weight, on adrenal 
weight, and on physical activity were observed. 
Megestrol acetate did not inhibit ovulation or fertility, and did not 
reduce ovarian weight; thus it did not have an anti-gonadotrophic 
effect at the dosages used. It affected vaginal cytology in a typical 
progestational fashion producing a constant diestrus or mixed cell 
smear. 
Body weight increased during treatment and remained fairly con-
stant after treatment stopped. Adrenal weight decreased during 
treatment and returned to normal after treatment stopped. These 
two effects may contribute to a decreased physical activity observed 
in some rats. Continuing obesity after treatment stopped may ac-
count for the failure of some rats to regain normal activity. Obesity 
may also be a factor in the inhibition of mating behavior observed in 
some of the animals. 
Progesterone is a steroid hormone produced by the corpus luteum. 
It normally functions to stimulate the uterine epithelium to secrete in 
anticipation of implantation of a fertilized ovum and is responsible for 
the constant diestrus vaginal cytology which is characteristic of preg-
nancy. It tends to inhibit ovulation by acting as an anti-gonadotrophin 
and may inhibit ACTH release or action when administered exogen-
ously (1). 
Synthetic progestins exhibit some of the same properties as proges-
terone, but not necessarily all of them nor to the same degre~ Some 
synthetic progestins, for example, may induce adrenal atrophy while 
others have no apparent effect ( 1). 
The following is a study of the effects of megestrol acetate ( 6-methyl-
17 ex: -acetoxypregna-4,6-diene-3,20-dione), a synthetic progestin, on 
mature female rats. It was initiated to study the anti-fertility prop-
erties of the drug and the effects of long term hormone therapy by 
means of slow release silasic ( dimethylpolysiloxane) capsules implanted 
subcutaneously. These capsules release the hormone at a constant rate 
a long as any hormone remains ( 2). They presumably, therefore, offer 
a method of administration which is constant rather than periodic as 
are most other methods. 
METHODS 
Silastic capsules (32 mm. long, 0.132" I.D., 0.183" O.D.) contain-
ing 5 mg. megestrol acetate suspended in 0.2 ml. sterile Upjohn sus-
pending media 100 were implanted subcutaneously in the dorsal region 
of mature female rats. These capsules release approximately 70 µ.g 
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of hormone per 24 hours per capsule in vitro (Kind, unpublished 
data). The rats were divided into three experimental and one control 
group of 15 animals each. Group I animals received one capsule, 
Group II animals received two capsules, and Group III animals re-
ceived four capsules implanted at two separate sites. The control group, 
Group IV, received one capsule per animal of suspending media only. 
The capsules were removed from five animals in each group 10 weeks 
after implantation. All surgery was performed using ether anesthesia. 
Food and water were supplied ad libidum. Vaginal smears were taken 
daily for two weeks during treatment and for three weeks after treat-
ment stopped. Smearing was started about three weeks after implanta-
tion of the capsules to minimize the effect of stress on the animals. 
Body weights were recorded at the start of treatment and periodically 
throughout the experiment. 
Males and females from each group were placed together in a ratio 
of three to two for three to seven days on Day 42 and again on Day 66 
after implantation. Daily smears for sperm were taken and females 
showing sperm was autopsied after 10 days. 
The general physical activity was observed and the four groups were 
compared qualitatively during and after treatment. 
The females were autopsied either after mating, during megestrol 
treatment, or after cessation of treatment. Body, adrenal, and ovarian 
weights, and the number of corpora lutea, were recorded in mated rats. 
The capsules were recovered and checked visually for the presence of 
the medication. It was visible in all cases and the availability of mege-
strol acetate was, therefore, assumed to be constant. 
RESULTS AND DISCUSSION 
Results are summarized in Tables 1 and 2 and in Figure 1. 
Table 1 
Cycling Pattern During and After Treatment 
After Treatment During Treatment 
Type of Cycle I II III IV I II III IV 
4-5 days .................. 15 5 2 4 5 
Irregular 
······ .... ······· 
9 6 2 1 
Not cycling 
··············· 
6 9 15 1 
Table 1: Megestrol acetate affected the cycling pattern in all experimental groups 
in proportion to the dosage. The controls, Group IV, exhibited a normal 4- to 5-
day cycling pattern. 
Ovulation occurred in all rats during treatment as indicated by the 
presence of corpora lutea in the ovaries of all rats. Ovarian weights 
were within the normal range. Normal fertility was indicated by com-
parable numbers of uterine implantation sites in the mated females from 
each group. These indicate that the ovary was not materially affected 
by megestrol treatment at the dosa~e~ 1Jsect. 
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Table 2 
Autopsy Data 
Mean Body Weight Mean Organ Weight Uterine 
Group (gms.) (mgs.) Implantation 
No. Initial Final Adrenals Ovaries Sites 
I 267 T 347 65.1 86.6 13.4 
p 368 77.4 89.0 
II 271 T 365 62.6 82.2 12.2 
p 363 75.5 84.2 
III 276 T 400 66.1 86.9 10.0 
p 388 80.1 80.7 
IV 273 T 340 79.7 104.9 12.5 
(Control) p 360 86.5 74.2 
Table 2: T: Data on rats autopsied during treatment. P: Data on rats autopsied 
after cessation of treatment. Standard error was calculated for all weights and for 
the number of uterine implantation sites. All weights and the number of uterine 
implantation sites were within one standard error except for the T final body 
weights of Groups II and III, the P final body weight of Group III, and the T 
adrenal weights of Groups I-III which were within two standard errors of the 
control weights. 
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Figure 1. The mean body weight gain is proportional to the dosage of megestrol 
acetate. 3
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The vaginal cytology, which normally exhibits a four- to five-day 
cyclical pattern, was affected in all treated groups and was normal in 
the controls. The degree of effect was roughly proportional to the 
dosage of the drug. No cyclical change was apparent in any of the 
Group III animals or in a large proportion of the Group I and II 
animals. Some of the Group I and II animals exhibited irregular cycl-
ing characterized by mixed-cell vaginal smears. The irregular cycling 
is probably due to concurrent effects of endogenous and exogenous 
hormones, while no apparent cycling is probably due to complete mask-
ing of the endogenous hormonal effects by the exogenous hormone. 
Vaginal cytology is ordinarily a reliable index of the ovarian cycle 
and the ovarian cycle is controlled by pituitary gonadotrophins. The 
release of gonadotrophins is controlled largely by the response of the 
hypothalamus to steroid hormone feedback from the ovaries. Exogen-
ous hormones may influence the vaginal cytology directly or via a 
pituitary-ovarian pathway. In the present study, the effect was ap-
parently local since the ovaries did not appears to be influenced. 
The vaginal cycling pattern returned to normal in most rats after 
treatment was stopped. The failure of a few animals to return to the 
normal cycling pattern may have been due to causes other than the 
treatment. In any case, the number of animals involved is too small 
to establish a positive correlation. 
Megestrol treatment resulted in increased body weight in animals 
in Groups II and III. The gain was proportional to the dosage. The 
variation in amount of gain from animal to animal within a given 
group, illustrated by a larger standard error in the calculated weight 
of treated groups, may be due to location of the capsule in regions with 
differing vascularity. A low vascular supply might reduce the rate of 
absorption of exogenous hormone. Another factor might be the for-
mation of fibroblast tissue around the capsules. This would reduce 
the rate of diffusion of hormone from the capsule. The animals did not 
lose weight after the capsules were removed, but neither did they con-
tinue to gain. 
Adrenal weight decreased slightly during treatment indicating pos-
sible adrenal suppression. This effect was reversible. The adrenals 
returned to normal weight after the progestin capsules were removed. 
Megestrol acetate treatment resulted in a decrease in apparent 
physical activity, especially in Group III. Most of the rats resumed 
normal activity after cessation of treatment. The decreased adrenal 
weight and decreased physical activity during treatment and the return 
to normal adrenal weight and physical activity after treatment suggests 
that the reduced activity may be due to decreased adrenal function. 
Another possible factor is obesity. The reduced activity remaining in 
some animals after treatment is probably a function of continuing 
obesity. 
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Inhibition of mating behavior in some animals may be related to 
obesity since in all cases animals which failed to mate were heavier 
than those which mated. 
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